Panel: The New Rules of Biotech Investing – What VCs Really Want in 2025

Session details:

Venture capital in biotech has entered a new era. Valuations are tighter, exits are murkier, and investors are asking harder questions earlier. But smart capital is still flowing - into the right science, the right teams, and the right business models. This panel brings together top VCs to cut through the noise and share what’s working, what’s not, and how biotech leaders can stand out when capital is more selective than ever.

• Understand what today’s investors look for in the first 5 minutes - and why
• Hear how timelines, syndicate dynamics, and exit expectations have shifted
• Learn how platform stories, modality trends, and early BD optionality shape investor decisions